Patents by Inventor Peter J.H. Jones

Peter J.H. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9345730
    Abstract: The invention is directed to methods of using Chlorella protothecoides microalgal biomass in the treatment of individuals having impaired glucose metabolism. In some cases, the patient has impaired fasting glucose, impaired glucose tolerance, or diabetes. In some methods, algal biomass is used to reduce blood glucose and/or body fat in a subject, or to increase the relative abundance of beneficial gut microflora in a subject. In preferred embodiments, the biomass is derived from Chlorella protothecoides cultures grown heterotrophically in which the algal cells comprise at least 15% algal oil by dry weight.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: May 24, 2016
    Assignees: SOLAZYME, INC., UNIVERSITY OF MANITOBA
    Inventors: David Brinkmann, Anthony G. Day, Peter J. H. Jones, Scott Harding
  • Publication number: 20140328906
    Abstract: The invention is directed to methods of using Chlorella protothecoides microalgal biomass in the treatment of individuals having impaired glucose metabolism. In some cases, the patient has impaired fasting glucose, impaired glucose tolerance, or diabetes. In some methods, algal biomass is used to reduce blood glucose and/or body fat in a subject, or to increase the relative abundance of beneficial gut microflora in a subject. In preferred embodiments, the biomass is derived from Chlorella protothecoides cultures grown heterotrophically in which the algal cells comprise at least 15% algal oil by dry weight.
    Type: Application
    Filed: April 30, 2014
    Publication date: November 6, 2014
    Applicants: Solazyme, Inc., University of Manitoba
    Inventors: David Brinkmann, Anthony G. Day, Peter J.H. Jones, Scott Harding
  • Patent number: 8747834
    Abstract: The invention is directed to methods of using Chlorella protothecoides microalgal biomass in the treatment of individuals having impaired glucose metabolism. In some cases, the patient has impaired fasting glucose, impaired glucose tolerance, or diabetes. In some methods, algal biomass is used to reduce blood glucose and/or body fat in a subject, or to increase the relative abundance of beneficial gut microflora in a subject. In preferred embodiments, the biomass is derived from Chlorella protothecoides cultures grown heterotrophically in which the algal cells comprise at least 15% algal oil by dry weight.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: June 10, 2014
    Assignees: Solazyme, Inc., University of Manitoba
    Inventors: David Brinkmann, Anthony G. Day, Peter J. H. Jones, Scott Harding
  • Publication number: 20120027724
    Abstract: The invention is directed to methods of using Chlorella protothecoides microalgal biomass in the treatment of individuals having impaired glucose metabolism. In some cases, the patient has impaired fasting glucose, impaired glucose tolerance, or diabetes. In some methods, algal biomass is used to reduce blood glucose and/or body fat in a subject, or to increase the relative abundance of beneficial gut microflora in a subject. In preferred embodiments, the biomass is derived from Chlorella protothecoides cultures grown heterotrophically in which the algal cells comprise at least 15% algal oil by dry weight.
    Type: Application
    Filed: March 3, 2010
    Publication date: February 2, 2012
    Applicant: Solazyme ,Inc.
    Inventors: David Brinkmann, Anthony G. Day, Peter J.H. Jones, Scott Harding